ALG-000184 / Aligos Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ALG-000184 / Aligos Therap
NCT04536337: A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Recruiting
1
336
Europe, RoW
ALG-000184, Placebo, Entecavir
Aligos Therapeutics
Chronic Hepatitis B
11/23
06/24

Download Options